The Complement-based Drug Development Summit 2017
In-Person Event
Nov 14 - 16, 2017
Boston, Massachusetts, USA
OVERVIEW
The Complement-based Drug Development Summit is organized by Hanson Wade and would be held during Nov 14 - 16, 2017 at Hyatt Regency Boston, Boston, Massachusetts, United States Of America.
The Complement-based Drug Development Summit is the first industry-dedicated meeting that focuses on the research and development of therapeutics to inhibit the complement pathway, providing safe and effective cures for a range of disease indications.
Across 3 content-packed days, the field's thought leaders from Alexion, True North, GSK, Alnylam and many more will be sharing their insight and lessons learned, collectively enabling the community to:
• Standardize Efficacy Assessment: Define the next steps toward achieving standardization of robust, functional assays in order to accurately determine treatment efficacy.
• Optimize Clinical Trial Design: Analyze methods for improving clinical trial design with case studies in patient recruitment and stratification, targeting, dosing, endpoints and sample handling.
• Manage Off-Target Effects: Enhance the management of off-target effects and approaches for minimizing infection risk.
• Achieve Regulatory Approval: Learn how best to navigate the regulatory landscape, examining guidelines and expectations to ensure that drugs gain market approval smoothly.
• Assess Inhibition Points: Analyze the most effective points of complement inhibition for the treatment of individual diseases and the selection of therapeutic approaches for inhibition.
Price :
Industry Conference Standard: USD 2699,
Academic Conference Standard: USD 1889,
Industry Gold: Conference and 2 workshops: USD 3797,
Academic Gold: Conference and 2 workshops: USD 2658,
Industry Silver: Conference and 1 workshop: USD 3298,
Academic Silver: Conference and 1 workshop: USD 2310,
Academic Workshop Only: USD 699,
Industry Workshop Only: USD 699
Speakers:
Ted Yednock, Michael Holers, Camille Bedrosian, Eva-Maria Nichols, Sandip Panicker, Nader Najafian, Cedric Francois, Michael McCaleb, Niels Riedemann, Ashley Frazer-Abel, Kishor Devalaraja, David Apelian, Sacha Zeerleder, Christopher Horvath, Menno van Beek, Rajendra Kumar-Singh, Jörg Köhl, Kourous Rezaei
Time: 8:00 am to 6:00 pm
Additional details will be posted as soon as they are available.
The Complement-based Drug Development Summit is the first industry-dedicated meeting that focuses on the research and development of therapeutics to inhibit the complement pathway, providing safe and effective cures for a range of disease indications.
Across 3 content-packed days, the field's thought leaders from Alexion, True North, GSK, Alnylam and many more will be sharing their insight and lessons learned, collectively enabling the community to:
• Standardize Efficacy Assessment: Define the next steps toward achieving standardization of robust, functional assays in order to accurately determine treatment efficacy.
• Optimize Clinical Trial Design: Analyze methods for improving clinical trial design with case studies in patient recruitment and stratification, targeting, dosing, endpoints and sample handling.
• Manage Off-Target Effects: Enhance the management of off-target effects and approaches for minimizing infection risk.
• Achieve Regulatory Approval: Learn how best to navigate the regulatory landscape, examining guidelines and expectations to ensure that drugs gain market approval smoothly.
• Assess Inhibition Points: Analyze the most effective points of complement inhibition for the treatment of individual diseases and the selection of therapeutic approaches for inhibition.
Price :
Industry Conference Standard: USD 2699,
Academic Conference Standard: USD 1889,
Industry Gold: Conference and 2 workshops: USD 3797,
Academic Gold: Conference and 2 workshops: USD 2658,
Industry Silver: Conference and 1 workshop: USD 3298,
Academic Silver: Conference and 1 workshop: USD 2310,
Academic Workshop Only: USD 699,
Industry Workshop Only: USD 699
Speakers:
Ted Yednock, Michael Holers, Camille Bedrosian, Eva-Maria Nichols, Sandip Panicker, Nader Najafian, Cedric Francois, Michael McCaleb, Niels Riedemann, Ashley Frazer-Abel, Kishor Devalaraja, David Apelian, Sacha Zeerleder, Christopher Horvath, Menno van Beek, Rajendra Kumar-Singh, Jörg Köhl, Kourous Rezaei
Time: 8:00 am to 6:00 pm
Additional details will be posted as soon as they are available.
KEY DATES
14 Nov, 2017
Event Start Date
16 Nov, 2017
Event End Date
SUGGESTED HOTELS
CONFERENCE VENUE
Hyatt Regency BostonQuick Links